Risk and prevention of hepatitis C virus infection: Implications for dentistry

Journal of the American Dental Association

Volumn 130, Issue 5, 1999, Pages 641-647

  Cleveland, Jennifer L ^a   Gooch, Barbara F ^c   Shearer, Brian G ^b   Lyerla, Rob L ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b AMERICAN DENTAL ASSOCIATION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DENTIST; DISEASE TRANSMISSION; HEPATITIS C; HUMAN; OCCUPATIONAL DISEASE; REVIEW; RISK FACTOR;

DENTISTS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEPATITIS C; HUMANS; OCCUPATIONAL DISEASES; RISK FACTORS;

EID: 0033127607     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1999.0273     Document Type: Article

References (44)

1. Mosley JW, Edwards VM, Casey G, Redeker AG, White E. Hepatitis B virus infection in dentists. N Engl J Med 1975;293:729-34.
2. Smith JL, Maynard JE, Berquist KR. From the Centers for Disease Control: comparative risk of hepatitis B among physicians and dentists. J Infect Dis 1976;133:705-6.
3. Reingold AL, Kane MA, Hightower AW. Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons. JAMA 1988;259:2558-60.
4. Klein RS, Phelan JA, Freeman K, et al. Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med 1988;318:86-90.
5. McQuillan G, Alter M, Moyer L, Lambert S, Margolis H. A population based serologic study of hepatitis C virus infection in the United States (abstract). Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease; Rome, Italy; 1996:8A.
6. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(no. RR-19):1-38.
7. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
8. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasi-species and genotypes. Semin Liver Dis 1995;15:41-63.
9. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
10. Healey CJ, Chapman RW, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1996;37:274-8.
11. Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am 1998;12:13-26.
12. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
13. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
14. National Institutes of Health. Management of hepatitis C. NIH Consens Statement 1997;15(3):1-41.
15. Centers for Disease Control and Prevention. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991;40(no. RR-4):1-17.
16. Hoofnagle JH, Di Bisceglie AM. Drug therapy: the treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
17. Schvarcz R, Yun ZB, Sonnerborg A, Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol 1995;46:43-7.
18. Schalm SE, Hansen BE, Chemello L, et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: meta-analysis of individual patient data from European centers. J Hepatol 1996;26:961-6.
19. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
20. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-9.
21. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
22. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
23. Cooper BW, Krusell A, Tilton RC, Goodwin R, Levitz RE. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82-5.
24. Panlilio AL, Shapiro CN, Schable CA, et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. J Am Coll Surg 1995;180:16-24.
25. Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196-200.
26. Shapiro CN, Tokars JI, Chamberland ME. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J Bone Joint Surg 1996;78:1791-9.
27. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994;170:1410-7.
28. Petrosillo N, Puro V, Ippolito G. Prevalence of hepatitis C antibodies in health-care workers: Italian Study Group on Blood-borne Occupational Risk in Dialysis. Lancet 1994;344:339-40.
29. Puro V, Petrosillo N, Ippolito G, Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995;23:273-7.
30. Lanphear BP, Linnemann CC Jr, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in health care workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994;15:745-50.
31. Zuckerman J, Clewley G, Griffiths P, Cockcroft A. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 1994;343:1618-20.
32. Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needle-stick accident. Hepatology 1992;16:1109-14.
33. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva (letter). Scand J Infect Dis 1993;25:270-1.
34. Ippolito G, Puro V, Petrosillo N, De Carli G, Micheloni G, Magliano E. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure (letter). JAMA 1998;280:28.
35. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
36. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539-42.
37. Gruninger SE, Siew C, Chang SB, et al. Hepatitis B, C, and HIV infection among dentists (abstract 2131). J Dent Res 1991;70:532.
38. Wisnom C, Depaola L, Lee R. Hepatitis C prevalence in dental practitioners and high risk patients (abstract 605). J Dent Res 1994;74:177.
39. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996;100:41-5.
40. Peters M, Davis GL, Dooley JS, Hoofnagle JH. The interferon system in acute and chronic viral hepatitis (review). Prog Liver Dis 1986;8:453-67.
41. Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR 1997;46:603-6.
42. Centers for Disease Control and Prevention. Recommended infection-control practices for dentistry, 1993. MMWR 1993;42(no. RR-8):1-12.
43. Cleveland JL, Gooch BF, Lockwood SA, Occupational blood exposures in dentistry: a decade in review. Infect Control Hosp Epidemiol 1997;18(10):717-21.
44. Camma C, Almasio P, Craxi A Interferon as treatment for acute hepatitis C: a meta-analysis. Dig Dis Sci 1996;41:1248-55.